| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 12/13/2007 | WO2007103529A3 Antisense antiviral compound and method for treating arenavirus infection |
| 12/13/2007 | WO2007021971A3 Labeling compositions and methods of use for deterrent trackability |
| 12/13/2007 | WO2007005616A3 Cell line and methods for determining viral titer |
| 12/13/2007 | WO2007002191A3 Methods for the preparation of 9-deazapurine derivatives |
| 12/13/2007 | WO2006138284A3 Nucleic acid analysis by random mixtures of non-overlapping fragments |
| 12/13/2007 | WO2006124758A3 Method for producing improved nucleic acid oligomer functional heterogeneity and functional characteristic information and results and oligomer application results |
| 12/13/2007 | WO2006115548A3 Subunit vaccine against west nile viral infection |
| 12/13/2007 | WO2006110735A3 Genotyping hla loci |
| 12/13/2007 | WO2006099286A3 Oligonucleotides for multiplexed binding assays |
| 12/13/2007 | WO2006081396A3 Compositions and methods for delivery of agents into cells |
| 12/13/2007 | WO2006074222A3 Primer for nucleic acid detection |
| 12/13/2007 | WO2006044663A3 THIO-siRNA APTAMERS |
| 12/13/2007 | WO2006036243A8 Methods for isolating nucleic acids from biological and cellular materials |
| 12/13/2007 | WO2006023755A3 A mutant met and uses therefor |
| 12/13/2007 | WO2005113822A3 Dna profiling and snp detection utilizing microarrays |
| 12/13/2007 | WO2005062923A3 Gene targets for enhanced carotenoid production |
| 12/13/2007 | WO2005062832A3 Enzyme expression methods |
| 12/13/2007 | WO2005017103A3 Bacterial nitric oxide synthases and uses thereof |
| 12/13/2007 | WO2005005602A3 Methods for the identification of inhibitors of fumarate reductase and vacuolar protein sorting-associated protein as antibiotics |
| 12/13/2007 | US20070287834 Method for mutation detection in HIV-1 using pol sequencing |
| 12/13/2007 | US20070287833 siRNA targeting minichromosome maintenance deficient 6 (MCM6) |
| 12/13/2007 | US20070287832 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports |
| 12/13/2007 | US20070287825 Constrained cis-diol-borate bioconjugation system |
| 12/13/2007 | US20070287682 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 12/13/2007 | US20070287681 siRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof |
| 12/13/2007 | US20070287678 Anti-aging micrornas |
| 12/13/2007 | US20070287677 Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof |
| 12/13/2007 | US20070287676 Diagnosis and treatment of endometriosis |
| 12/13/2007 | US20070287667 Chimpanzee monoclonal antibodies and antigen binding fragments including variable region peptides; bioassay for detection of hepatitis A virus; diagnosis, treatment and prevention of hepatitis; kits |
| 12/13/2007 | US20070287660 Chimeric metalloenzyme comprising fibrin binding domain for for use in treatment and prevention of thrombosis and cardiovascular disorders |
| 12/13/2007 | US20070287180 Linear Dna Fragment For Markerless Deletion, Novel Strain Having Inhibited Formation Of Biofilm And Preparation Method Thereof |
| 12/13/2007 | US20070287179 Inhibiting ribonucleoprotein particles (miRNPs) activity in a cell |
| 12/13/2007 | US20070287175 Sirna That Inhibits Wt1 Gene Expression And Uses Thereof |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070287172 Culturing a host cell that includes a recombinant expression vector, wherein the recombinant expression vector includes a nucleic acid sequence encoding a polypeptide elicits an immune response; penumonia treatment |
| 12/13/2007 | US20070287171 Process for production of proteins as soluble proteins |
| 12/13/2007 | US20070287170 Engineered heterodimeric protein domains |
| 12/13/2007 | US20070287163 Methods for Diagnosis of Acute Myeloid Leukemia |
| 12/13/2007 | US20070287151 Methods and Means for Nucleic Acid Sequencing |
| 12/13/2007 | US20070287148 Detection and identification of enteroviruses |
| 12/13/2007 | US20070286874 Recombinant attenuated clostridium organisms and vaccine |
| 12/13/2007 | US20070286871 Vaccines |
| 12/13/2007 | US20070286862 Cancer Associated Antigens |
| 12/13/2007 | US20070286858 Methods and Compositions for Antagonism of RAGE |
| 12/13/2007 | US20070286856 Enzyme is a drug target; cancer, inflammatory diseases such as psoriasis |
| 12/13/2007 | US20070286850 Mevalonate Kinase |
| 12/13/2007 | US20070286807 Method Of Inducing Or Modulating Immune Response |
| 12/13/2007 | CA2771971A1 Gene involved in immortalization of human cancer cell and use thereof |
| 12/13/2007 | CA2654165A1 Assessment of risk for colorectal cancer |
| 12/13/2007 | CA2652975A1 Gene methylation in cancer diagnosis |
| 12/13/2007 | CA2651042A1 Compounds and methods for modulating expression of sglt2 |
| 12/13/2007 | CA2628116A1 Compositions and methods for diagnosing and treating cancer |
| 12/13/2007 | CA2548375A1 Assessment of risk for colorectal cancer |
| 12/12/2007 | EP1864134A2 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| 12/12/2007 | EP1863938A2 Oligonucleotides for multiplexed binding assays |
| 12/12/2007 | EP1863935A2 Methods and kits for detection of chromosome aneuploidy by high performance liquid chromatography with post-column fluorescence detection |
| 12/12/2007 | EP1863914A1 Tuberculosis vaccine and method for making same |
| 12/12/2007 | EP1863848A2 Antibodies and related molecules that bind to 161p2f10b proteins |
| 12/12/2007 | EP1863844A1 Heterodimeric protein binding compositions |
| 12/12/2007 | EP1863828A2 Stabilized aptamers to psma and their use as prostate cancer therapeutics |
| 12/12/2007 | EP1863538A2 Direct reversal of the suppressive function of cd4+ regulatory t cells via toll-like receptor 8 signaling |
| 12/12/2007 | EP1863335A2 Eg1117 and eg307 polynucleotides and uses thereof |
| 12/12/2007 | EP1799847A4 Simplified methods for isolating nucleic acids from cellular materials |
| 12/12/2007 | EP1766053A4 Rna-containing microvesicles and methods therefor |
| 12/12/2007 | EP1546387A4 Microarray synthesis and assembly of gene-length polynucleotides |
| 12/12/2007 | EP1366192B1 Direct multiplex characterization of genomic dna |
| 12/12/2007 | EP0888377B1 MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII) |
| 12/12/2007 | CN101087801A Branched polymeric sugars and nucleotides thereof |
| 12/12/2007 | CN101087527A RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof |
| 12/12/2007 | CN101085799A Method for extracting nucleic acid |
| 12/12/2007 | CN101085773A Polyamide bisbenzimidazole compound, preparation method and application thereof |
| 12/12/2007 | CN100354431C Method of PCR testing of pooled blood samples |
| 12/12/2007 | CN100354419C Wheat yellow dwarf disease candidate resistance gene and its coded protein and uses |
| 12/12/2007 | CN100354297C Adjuvanted meningococcus compositions |
| 12/12/2007 | CN100354295C Organic compounds of 2'-o-trisubstituted siloxy methyl ribonucleoside derivatives and their preparation |
| 12/11/2007 | US7308364 Diagnosis of multiple myeloma on gene expression profiling |
| 12/11/2007 | US7307161 Human Gil-19/AE289 polynucleotides |
| 12/11/2007 | US7307160 OtsA gene encoding trehalose-6-phosphate synthase from a coryneform bacterium |
| 12/11/2007 | US7307159 Nucleotide sequences for use in the diagnosis and prevention of bacterial infections |
| 12/11/2007 | US7307158 Selection marker gene |
| 12/11/2007 | US7307153 Antibodies that bind PRO9912 |
| 12/11/2007 | US7307147 Latent fusion protein |
| 12/11/2007 | US7307144 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 12/11/2007 | US7307069 Inflammatory diseases and cancers; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 12/11/2007 | US7306946 Antifungal polypeptides |
| 12/11/2007 | US7306939 Genetic engineering |
| 12/11/2007 | US7306937 Multiply-substituted protease variants |
| 12/11/2007 | US7306935 Enzymatic polypeptide for use in enhancing starch liquefaction, textile desizing, brewing, baking and starch modification in paper and pulp processing |
| 12/11/2007 | US7306933 Method for producing L-lysine or L-threonine |
| 12/11/2007 | US7306932 Coryneform bacteria with altered glucokinase activity in the production of L-lysine |
| 12/11/2007 | US7306927 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer |
| 12/11/2007 | US7306922 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
| 12/11/2007 | US7306918 Testing of an organism and correlating the results with a unique marker (single nucleotide polymorphism or short tandem repeats) that identifies the sample; contacting a target sequence with oligonucleotide probes, interrogating the hybridization complexes, decoding |
| 12/11/2007 | US7306917 Structure-specific nuclease activity of a variety of enzymes is used to cleave the target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations |
| 12/11/2007 | US7306916 Methods for detecting chromosome aberrations |
| 12/11/2007 | US7306915 Nucleic acid contained even in a very small amount in a sample can be detected with a strong signal; nucleic acids, proteins, hormones, neurotransmitters, autacoids, haptens, viruses or cells of microorganisms, pollens, does not require thermal denaturation |
| 12/11/2007 | US7306913 Using single nucleotide polymorphisms to diagnose cardiovascular and vascular disorders |
| 12/11/2007 | US7306911 KCNJ2 gene or the Kir2.1 is screened for alteration as compared to the wild-type sequence; alteration in a copy of the KCNJ2 gene or a Kir2.1 polypeptide indicates high risk for developing a cardiac dysrhythmia and can be diagnosed with Andersen's Syndrome |
| 12/11/2007 | US7306909 Canola event pv-bngt04(rt73) and compositions and methods for detection thereof |
| 12/11/2007 | US7306908 Mutant Dna; transcription of genomes |